TIDMCFGP

RNS Number : 3571M

Continental Farmers Group PLC

17 September 2012

07:00, 17 September 2012

Continental Farmers Group Plc.

Interim report

Continental Farmers Group PLC (AIM: CFGP, ESM: CT3, "CFG" or "the Group"), the Ukrainian and Polish agricultural crop producer, announces its results for the six months ended 30 June 2012.

Highlights

   --          Pre-tax profit for the six months of EUR3.5m +202%, 
   --          EBITDA for the six months of EUR5.6m +104%. 
   --          Equalised earnings per share of 2.1 cents +192%. 

-- 26,100 hectares under crop for 2012 harvest, up 42% on 2011 (excluding the 2,982 hectares harvested in the Mykolaiv Joint Venture with ED&F Man).

   --          Trial plantings in Mykolaiv Joint Venture have performed well to date. 
   --          EUR8.1m capital expenditure invested in support of the expanded operations. 

Post 30 June 2012 Update:

-- Wheat and oil seed rape harvest successfully completed in Ukraine and Poland by 23 August 2012.

-- Winter oil seed rape average net yield 3.2 tonnes per hectare in Ukraine and 3.9 tonnes in Poland.

-- Winter wheat average net yield 6.2 tonnes per hectare in Ukraine and 8.1 tonnes in Poland.

-- Spring wheat average net yield 4.6 tonnes per hectare in Ukraine and 7.6 tonnes in Poland.

-- Strong market prices for cereals. Majority of Ukraine oil seed rape contracted at an average price of EUR445/ tonne.

-- Autumn plantings of oil seed rape have been completed and winter wheat planting is underway.

   --          Land bank in place to enable planned growth in hectares under harvest for 2013. 

Commenting on the interim results Nick Parker, CFG Chairman stated "While this is the report for the half year to 30 June 2012, it is also the first anniversary of the Group's listing and we can look back on 12 months which have seen the delivery of the 2011 results in line with market expectation and a significant growth in land harvested in line with our plans.

The increased tonnage in our cereal crops grown and harvested is a testament to the efforts made in planning, agronomy and execution, supported by substantial capital expenditure. These efforts have produced crops of high quality and good yields, which are further benefitting from firm market prices.

Our focus for 2012/13 will be to embed and benefit from the productivity improvements in agronomy and farming practices and the capacity increases provided by recent capital expenditure.

Our JV with ED&F Man has started successfully. This model of partnership working is one which we will seek to extend.

Investment by the capital markets in agriculture has been growing worldwide and there is a continuing search by investors for opportunities to invest in primary agriculture. Increasingly, food security, coupled with land reform and land tenure rights, are being discussed at governmental and corporate levels. We keep close contacts with these developments in our markets and are well placed to participate in the future opportunities which they may offer.

The cereal harvest has provided a good start to the year. Subject to no material adverse change, we expect to exceed management's targets for the year."

Commenting on the interim results Mark Laird, CEO stated, "CFG has reached another successful milestone in its journey to be one of the most efficient and profitable large scale food producers in Central Europe. The successful completion of the cereal harvest, delivering improved yields under exceptionally difficult climatic conditions, whilst significantly increasing our hectares under harvest underlines the Know How Do How capability that exists within the company. The business continues to hold a significant percentage of harvested cereals in store whilst the typical seasonal glut of crops finds its way on to the market. The harvest of the root crops has got off to a good start and, given the adverse weather conditions in other parts of Europe, the markets for these crops look promising.

With the first phase of the autumn plantings completed in both Poland and Ukraine and the securing of the land required for further growth in 2013, the company is looking at how best to maximise earnings potential, given the strong commodity prices and the longer term prospects for the crops CFG typically grows. A percentage of the 2013 crop has been forward sold as would be typical in previous years.

The climatic challenges throughout Europe and indeed across the World demonstrate the importance of our choice of location and of our strategy of rotation and diversification. In a year of difficult growing conditions our farms are delivering strong yields across our range of crops. This success is vindication of our business model and provides us with further encouragement as we expand within our regions of operation. The Joint Venture Model already in place with ED & F Man is developing in a sustainable and controlled manner and it is likely that this strategy will be used with more potential partners in other sectors of CFG's business.

The focus of management remains on the development of precision farming and business expertise within the company and whilst at the same time drilling down on the daily detail of running a large farming operation. Working closely with the various local communities, within which the business operates remains core, and completely aligned, to the overall objective of growing the business for the longer term."

For further information:

Continental Farmers Group Plc (http://www.continentalfarmersgroup.com)

 
 Mark Laird, Chief Executive 
 Alastair Stewart, Chief        + 44 (0) 7917 435 
  Financial Officer              224 
 

Davy

 
 John Frain / Anthony 
  Farrell                +353 1 679 6363 
 

Murray Consultants

 
 Joe Murray    + 353 (0) 1 498 0300 
               + 353 (0) 1 498 0300 
 Joe Heron      + 353 (0) 87 690 9735 
 

Financial review

Revenues of EUR4.2m relate to the sales of 2011 harvested crops stored since the end of last harvest. The reduction on prior year reflects the lower year on year potato pricing in Ukraine.

As in the prior year we are required to record the fair valuation of our growing crops at 30 June. The assessment of this is especially complex for certain crops where there is still a significant time from the date of harvest and there is a limited market to forward sell these products. We have therefore continued to take a consistent approach to this valuation, applying risk discounts to the yields and pricing. This is outlined in more detail in note 3 to the attached accounts. The year on year increase in biological assets as driven by a combination of; significantly increased hectares under harvest especially in cereals which are near completion at half year, higher yields, stronger commodity pricing and significantly stronger local currencies against 30 June 2011.

Cost of Sales totaled EUR3.7m (2011: EUR3.9m) and relate to the costs associated with the sale of last year's

harvest. Administrative expenses increased to EUR4.3m (2011: EUR3.3m) reflecting the increased scale of the Ukraine operations and the costs of operating as a quoted plc.

The taxation charge recorded in the period arose in Ukraine as the Polish farming operations are not subject to corporation tax.

Operating cash outflows for the first 6 months of 2012 reflect the seasonal nature of our business and the substantial investment in infrastructure. We will continue to invest in the business in 2012/13 and are comfortable with our ability to fund this. As at 30 June 2012 the Group had cash and cash equivalents of EUR5.2m held on deposit with high credit quality UK banks. The EUR16.2m of current borrowings comprise short term working capital facilities in Ukraine and that element of shareholder loans and asset finance funding repayable within 1 year. These are due to be repaid from harvest receipts prior to the year end.

Between 31 December 2011 and 30 June 2012, both the Ukrainian Hryvnia and the Polish Zloty strengthened against the Euro. As a consequence, the translation of the Ukrainian and Polish balance sheets on consolidation resulted in a EUR1.8m currency translation gain through Other Comprehensive Income.

Operational review

CFG's farming operations continue to apply the full, five crop rotational programme, which provides risk diversification in cropping, thus reducing the volatility of Group earnings both in terms of climatic conditions and market prices. The team remain focused on yield maximisation through the application of the latest agronomy and environmental practices to complement this rotational programme. The Group further manages the crop risk through planting a mix of crops in both its summer and winter planting.

The hectares planted and net yields achieved to date, for those crops harvested are as follows:

Ukraine - (excl Mykolaiv JV)

 
 Crop               Hectares Planted        Tonnes per 
                                              Hectare 
----------------  -------------------  -------------------- 
                     2012      2011       2012       2011 
----------------  ---------  --------  ---------  --------- 
 Potatoes           1,347      1,309     Not yet harvested 
----------------  ---------  --------  -------------------- 
 Oil Seed Rape 
  - Winter          8,895      4,715      3.2        2.9 
   *    Spring        745       501        1.6        2.6 
----------------  ---------  --------  ---------  --------- 
 Wheat - Winter     4,198      3,008      6.2        6.1 
   *    Spring       2,181     1,408       4.6        5.0 
----------------  ---------  --------  ---------  --------- 
 Maize              1,185      1,905     Not yet harvested 
----------------  ---------  --------  -------------------- 
 Sugar Beet         4,950      3,002     Not yet harvested 
----------------  ---------  --------  -------------------- 
 Other               154        78       Not yet harvested 
----------------  ---------  --------  -------------------- 
 Total              23,655    15,926 
----------------  ---------  -------- 
 

Poland

 
 Crop               Hectares Planted        Tonnes per 
                                              Hectare 
----------------  -------------------  -------------------- 
                     2012      2011       2012       2011 
----------------  ---------  --------  ---------  --------- 
 Oil Seed Rape 
  - Winter           636        569       3.9        2.9 
  - Spring            22         34        1.8        2.0 
----------------  ---------  --------  ---------  --------- 
 Wheat - Winter     1,301      1,396      8.1        7.2 
  - Spring            81        105        7.6        6.0 
----------------  ---------  --------  ---------  --------- 
 Sugar Beet          405        338      Not yet harvested 
----------------  ---------  --------  -------------------- 
 Total              2,445      2,442 
----------------  ---------  -------- 
 

Agricultural markets

Weak potato pricing resulting from the 2011 harvest oversupply position has continued through to early 2012 as these stocks were sold through the market. Global prices have strengthened over the last 6 months due to the poor climatic conditions in the USA and following the difficult autumn and winter conditions in Eastern Europe. These are especially evident in cereal and oil seed rape prices.

Storage and logistics

The Group has continued to invest in its infrastructure, increasing its Ukraine cereal storage capacity by 15,000 tonnes with further investments being made in potato handling, grading and bagging equipment. All of these investments are focused on delivering increased quality and improving our flexibility in managing inventory and being able to take advantage of peak seasonal pricing.

Current trading and outlook

Subject to no material adverse change in climate or market prices we expect to exceed management's targets for the year, and we are on track with our winter plantings of wheat and oil seed rape.

We continue to investigate a number of opportunities to deliver the controlled expansion of our farming operations and available land under management. We also continue to develop new customers and markets for our crops both within Ukraine and Poland and for export. These opportunities will further diversify our income sources; reduce the effect of localised weather conditions and mitigate international pricing volatility.

Condensed Consolidated Statement of Comprehensive Income - Unaudited

For the 6 month period ended 30 June 2012

 
                              Unaudited   Unaudited     Audited 
                               6 months    6 months     12 months 
                                ended       ended         ended 
                               30 June     30 June     31 December 
                                 2012        2011         2011 
                               EUR'000     EUR'000       EUR'000 
 Continuing operations 
  Revenue                         4,190       4,372         25,034 
  Gains arising 
   from changes in 
   the value of biological 
   assets                         7,786       4,290              - 
  Cost of sales                 (3,661)     (3,880)       (15,938) 
 Gross profit                     8,315       4,782          9,096 
---------------------------  ----------  ----------  ------------- 
  Administrative 
   expenses                     (4,279)     (3,343)        (6,283) 
  Other operating 
   income                           333         421          1,697 
 Operating profit                 4,369       1,860          4,510 
---------------------------  ----------  ----------  ------------- 
  Finance income                     32           6             32 
  Finance costs                   (921)       (713)        (1,457) 
---------------------------  ----------  ----------  ------------- 
 Profit before 
  income tax                      3,480       1,153          3,085 
---------------------------  ----------  ----------  ------------- 
  Earnings from                      29           -              - 
   joint venture 
   operations 
  Income tax                      (124)           -           (17) 
---------------------------  ----------  ----------  ------------- 
 Profit for the 
  period                          3,385       1,153          3,068 
---------------------------  ----------  ----------  ------------- 
 
 Other comprehensive 
  income net of 
  tax 
  Currency translation 
   differences                    1,787     (2,162)              3 
---------------------------  ----------  ----------  ------------- 
 Total comprehensive 
  income for the 
  period                          5,172     (1,009)          3,071 
---------------------------  ----------  ----------  ------------- 
 
 Profit for the 
  period attributable 
  to: 
  Equity holders 
   of the company                 3,385       1,153          3,068 
  Non-controlling                     -           -              - 
   interests 
---------------------------  ----------  ----------  ------------- 
                                  3,385       1,153          3,068 
 Total comprehensive 
  income for the 
  period attributable 
  to: 
  Equity holders 
   of the company                 5,172     (1,009)          3,071 
  Non-controlling                     -           -              - 
   interests 
---------------------------  ----------  ----------  ------------- 
                                  5,172     (1,009)          3,071 
 Earnings per share 
  (expressed as 
  Euro cents per 
  share) 
  Basic earnings 
   per share                       2.07        1.39           2.47 
  Equalised earnings 
   per share (see 
   Note 2)                         2.07        0.71           1.88 
---------------------------  ----------  ----------  ------------- 
 
 
 

Condensed Consolidated Statement of Financial Position - Unaudited

As at 30 June 2012

 
                                 Unaudited   Unaudited     Audited 
                                  30 June     30 June     31 December 
                                    2012        2011         2011 
                                  EUR'000     EUR'000       EUR'000 
 Assets 
 Non-current assets 
  Property, plant and 
   equipment                        44,681      32,969         37,806 
  Intangible assets                 22,140      22,140         22,140 
  Investment in joint                1,788           -              - 
   venture 
------------------------------  ----------  ----------  ------------- 
                                    68,609      55,109         59,946 
------------------------------  ----------  ----------  ------------- 
 Current assets 
  Biological assets                 31,066      16,207          5,297 
  Inventories                        2,554       1,926          8,791 
  Trade and other receivables        8,357       4,015         10,035 
  Cash and cash equivalents          5,160      16,888         10,036 
------------------------------  ----------  ----------  ------------- 
                                    47,137      39,036         34,159 
------------------------------  ----------  ----------  ------------- 
 Total assets                      115,746      94,145         94,105 
------------------------------  ----------  ----------  ------------- 
 
 Capital and reserves attributable to 
  the equity holders of the Company 
  Share capital                      1,635       1,635          1,635 
  Share premium                     68,795      68,907         68,795 
  Retained profits                   7,499       2,199          4,114 
  Foreign exchange 
   reserve                         (2,025)     (5,977)        (3,812) 
 Total equity attributable 
  to the equity holders 
  of the Company                    75,904      66,764         70,732 
  Total equity attributable 
   to non-controlling 
   interests                         1,596       1,596          1,596 
------------------------------  ----------  ----------  ------------- 
 Total equity                       77,500      68,360         72,328 
------------------------------  ----------  ----------  ------------- 
 
 Non-current liabilities 
  Borrowings                        10,165       9,821          6,072 
------------------------------  ----------  ----------  ------------- 
                                    10,165       9,821          6,072 
------------------------------  ----------  ----------  ------------- 
 Current liabilities 
  Trade and other payables          10,798       8,717          4,977 
  Income tax payable                 1,073         499            412 
  Borrowings                        16,210       6,748         10,316 
                                    28,081      15,964         15,705 
------------------------------  ----------  ----------  ------------- 
 
 Total liabilities                  38,246      25,785         21,777 
------------------------------  ----------  ----------  ------------- 
 
 Total liabilities 
  and shareholders 
  equity                           115,746      94,145         94,105 
------------------------------  ----------  ----------  ------------- 
 
 

Condensed Consolidated Statement of Changes in Equity - Unaudited

For the 6 month period ended 30 June 2012

 
                                                                          Total 
                                                                          Equity 
                                               Foreign                 Attributable 
                         Share      Share      Exchange   Retained      to Equity     Non-controlling    Total 
                         Capital    Premium    Reserve     Earnings      Holders          interest       Equity 
                         EUR'000    EUR'000    EUR'000     EUR'000       EUR'000          EUR'000        EUR'000 
 Balance 
  at 31 December 
  2010 (audited)             829     52,069     (3,815)       1,329          50,412             1,313     51,725 
---------------------  ---------  ---------  ----------  ----------  --------------  ----------------  --------- 
 
 Profit for 
  the period                   -          -           -       1,153           1,153                 -      1,153 
 Currency 
  translation 
  differences                  -          -     (2,162)           -         (2,162)                 -    (2,162) 
 Acquisition 
  of non-controlling 
  interest                     -          -           -       (283)           (283)               283          - 
 Conversion 
  of preference 
  shares                     166      2,627           -           -           2,793                 -      2,793 
 Proceeds 
  from equity 
  issue                      640     16,073           -           -          16,713                 -     16,713 
 Costs of 
  equity issue                 -    (1,862)           -           -         (1,862)                 -    (1,862) 
---------------------  ---------  ---------  ----------  ----------  --------------  ----------------  --------- 
 Balance 
  at 30 June 
  2011 (unaudited)         1,635     68,907     (5,977)       2,199          66,764             1,596     68,360 
---------------------  ---------  ---------  ----------  ----------  --------------  ----------------  --------- 
 
 Profit for 
  the period                   -          -           -       1,915           1,915                 -      1,915 
 Currency 
  translation 
  differences                  -          -       2,165           -           2,165                 -      2,165 
 Final costs 
  of equity 
  issue                        -      (112)           -           -           (112)                 -      (112) 
 Balance 
  at 31 December 
  2011 (audited)           1,635     68,795     (3,812)       4,114          70,732             1,596     72,328 
---------------------  ---------  ---------  ----------  ----------  --------------  ----------------  --------- 
 
 Profit for 
  the period                   -          -           -       3,385           3,385                 -      3,385 
 Currency 
  translation 
  differences                  -          -       1,787           -           1,787                 -      1,787 
 Balance 
  at 30 June 
  2012 (unaudited)         1,635     68,795     (2,025)       7,499          75,904             1,596     77,500 
---------------------  ---------  ---------  ----------  ----------  --------------  ----------------  --------- 
 
 

Condensed Consolidated Statement of Cash Flows - Unaudited

For the 6 month period ended 30 June 2012

 
                                       Unaudited   Unaudited     Audited 
                                        6 months    6 months     12 months 
                                         ended       ended         ended 
                                        30 June     30 June     31 December 
                                          2012        2011         2011 
                                        EUR'000     EUR'000       EUR'000 
 Cash flows from operating 
  activities 
 Profit before tax                         3,480       1,153          3,085 
 Adjusted for: 
  Depreciation and amortization            1,197         863          2,169 
  (Gain)/loss on sale of 
   assets                                      -        (80)            281 
  Earnings from joint venture                 29           -              - 
   operations 
 Fair value adjustment 
  recognised in the statement 
  of comprehensive income: 
  Biological assets                      (7,786)     (4,290)              - 
 Non-operating costs/income 
  in the statement of comprehensive 
  income: 
  Interest income                           (32)         (6)           (32) 
  Interest costs                             921         713          1,457 
 Movements in working 
  capital: 
  Decrease/(increase) in 
   inventories                             6,237       5,615          (844) 
  Decrease/(increase) in 
   receivables                             1,678         148        (5,872) 
  Increase in payables                     6,692       4,980          1,848 
  Income tax paid                          (164)           -          (154) 
  Net additions to biological 
   assets                               (17,982)     (9,400)        (3,186) 
------------------------------------  ----------  ----------  ------------- 
 Net cash used in operations             (5,730)       (304)        (1,248) 
------------------------------------  ----------  ----------  ------------- 
 Cash flows from investing 
  activities 
  Purchase of property, 
   plant and equipment                   (8,074)     (2,501)        (7,903) 
  Proceeds from sales of 
   assets                                      2         111            114 
  Purchase of non-controlling 
   interest                              (1,788)       (114)          (119) 
  Interest received                           32           6             32 
 Net cash used in investing 
  activities                             (9,828)     (2,498)        (7,876) 
------------------------------------  ----------  ----------  ------------- 
 Cash flows from financing 
  activities 
  Proceeds from issue of 
   ordinary shares                             -      16,713         16,713 
  Costs of issue of ordinary 
   shares                                      -     (1,862)        (1,973) 
  Repayment of shareholder 
   loans                                   (924)       (930)        (2,376) 
  Proceeds of borrowings                  10,911       4,313          5,540 
  Interest paid                          (1,092)       (339)        (1,326) 
 Net cash from financing 
  activities                               8,895      17,895         16,578 
------------------------------------  ----------  ----------  ------------- 
 
 Net (decrease)/increase 
  in cash and cash equivalents           (6,663)      15,093          7,454 
------------------------------------  ----------  ----------  ------------- 
 
  Cash and equivalents 
   at beginning of period                 10,036       2,579          2,579 
  Effect of foreign exchange 
   variances                               1,787       (784)              3 
------------------------------------  ----------  ----------  ------------- 
 Cash and cash equivalents 
  at end of period                         5,160      16,888         10,036 
 
 
 

Notes to the consolidated interim financial information - unaudited

1. Basis of preparation of financial information

This report was approved by the Directors on 14 September 2012.

The auditors' report for the year ended 31 December 2011 financial information was unqualified.

The condensed consolidated interim financial information has been prepared on the same basis and using the same accounting policies as were applied in drawing up the Group's statutory financial information for the year ended 31 December 2011, and those accounting policies which the Directors anticipate will be applied for the year ending 31 December 2012.

They have not been prepared in accordance with IAS 34 Interim Financial Reporting. They do not include all of the information required for full annual financial information, and should be read in conjunction with the consolidated financial information for the year ended 31 December 2011. The financial information is presented in Euro.

The financial information for the six months ended 30 June 2012 and 30 June 2011 is unaudited.

In the opinion of the Directors the financial information for this period presents fairly the financial position, results of operations and cash flows for the period in accordance with the recognition and measurement principles of the International Financial Reporting Standards ('IFRS') as adopted by the EU.

2. Earnings per ordinary share

Basic earnings per share have been calculated on the profit or loss after taxation for the period and the weighted average number of ordinary shares. The historic equalised earnings per share was calculated on the profit and loss after taxation for the period and the number of shares in issue subsequent to the listing of the company on 28 June 2011. In the opinion of the Directors, these provide shareholders with more appropriate representation of the comparative underlying earnings derived from the Group's businesses.

3. Biological assets

CFG's estimate of the fair value of its biological assets as at 30 June 2012 is EUR31.1m (2011: EUR16.2m). The cost of production of these assets was EUR23.2m (2011: EUR11.9m), resulting in a gain of EUR7.8m (2011: EUR4.3m). This gain takes into account the amount of biological transformation at the reporting date, along with the Group's estimate of the condition of the crops, and cost, yield, and sales price expectations.

The following is an outline of the basis of estimation for the biological asset fair value:

- Yields were estimated by the agronomy team based on the crop conditions prevailing at 30 June 2012.

- Sales prices have been estimated taking account of any forward contracted sales or hedging as well as market prices prevailing at 30 June 2012.

   -     Yields are discounted depending upon the time between half year and the eventual harvest. 

- Price estimates are then discounted, the percentage reflecting the volatility of the market, whether crops have been sold forward or hedged and the time between half year and the likely date of sale.

- From this resulting fair value, we deduct the anticipated remaining costs of harvest, drying and storage as well as the expected selling and distribution costs. This net figure is then used as the fair value of the growing crops and any difference between this, and the actual costs incurred to date in bringing the crops to their current state, is recognised in the results for the period.

This information is provided by RNS

The company news service from the London Stock Exchange

END

IR LLFSRASISLIF

Continential Fa (LSE:CFGP)
Gráfica de Acción Histórica
De Abr 2024 a May 2024 Haga Click aquí para más Gráficas Continential Fa.
Continential Fa (LSE:CFGP)
Gráfica de Acción Histórica
De May 2023 a May 2024 Haga Click aquí para más Gráficas Continential Fa.